Biopolymers Research
Open Access

Sugar-based biopolymers; Nanomedicine; Cancer imaging; Targeted drug delivery; Biodegradable Nano carriers; Cancer therapy; Biocompatibility

Introduction

Cancer remains one of the leading causes of mortality worldwide, driving the need for innovative approaches in diagnosis and treatment. Nanomedicine has emerged as a powerful tool in this fight, offering novel strategies for targeted drug delivery and enhanced imaging. Among the various materials explored for these applications, sugar-based biopolymers have garnered significant attention due to their unique properties, including biocompatibility, biodegradability, and their ability to form stable complexes with drugs and imaging agents [1]. Sugar-based biopolymers, such as dextran, chitosan, and hyaluronic acid, are derived from naturally occurring polysaccharides. These materials have shown great promise in forming Nano carriers that can encapsulate therapeutic agents and deliver them specifically to cancer cells, minimizing damage to healthy tissues. Additionally, their natural affinity for cell surface receptors, such as CD44, which are overexpressed in many cancers, enhances their potential for targeted therapy and imaging [2]. The application of sugar-based biopolymers in nanomedicine is rapidly evolving, with new formulations and functionalization’s being developed to improve their efficacy and specificity. This paper reviews the latest advancements in the design and application of sugar-based biopolymer Nano carriers in cancer imaging and therapy, highlighting their potential to revolutionize cancer treatment.

Results and Discussion

Synthesis and characterization of sugar-based biopolymer Nano carriers

Synthesis Techniques: Various synthesis techniques were employed to develop sugar-based biopolymer Nano carriers, including self-assembly, emulsification, and Nano precipitation. Each method was optimized to achieve the desired particle size, surface charge, and drug loading efficiency [3]. For instance, dextran-based nanoparticles were synthesized using an emulsification process, resulting in particles with a size range of 100-200 nm, ideal for passive targeting via the enhanced permeability and retention (EPR) effect. The choice of synthesis method significantly impacts the physicochemical properties of the Nano carriers, which in turn influence their bio distribution, cellular uptake, and therapeutic efficacy [4]. Optimizing these parameters is crucial for developing effective sugar-based biopolymer systems.

Targeted drug delivery and therapeutic efficacy

Targeting Efficiency: The sugar-based biopolymers demonstrated high targeting efficiency in in vitro and in vivo models. Chitosan nanoparticles functionalized with folic acid showed enhanced binding to folate receptors on cancer cells, leading to increased intracellular drug accumulation. In vivo studies using a mouse model of breast cancer revealed that hyaluronic acid-based nanoparticles preferentially accumulated in tumor tissue, reducing tumor growth more effectively than non-targeted systems [5,6]. The targeting capability of sugar-based biopolymers is largely attributed to their ability to interact with specific cell surface receptors, such as CD44 and folate receptors. This specificity enhances the therapeutic index of the Nano carriers, reducing off-target effects and improving patient outcomes.

Imaging Capabilities

Imaging Contrast Enhancement: Sugar-based biopolymer Nano carriers were loaded with imaging agents such as gold nanoparticles and quantum dots to enhance imaging contrast [7]. Dextran-coated gold nanoparticles demonstrated superior contrast in X-ray imaging, allowing for clear delineation of tumor margins in small animal models. Additionally, chitosan-based nanoparticles labeled with near-infrared dyes provided high-resolution imaging of deep tissue tumors, facilitating precise tumor localization during surgical procedures [8]. The ability to integrate imaging agents into sugar-based Nano carriers provides a dual function of therapy and diagnosis, known as theranostics. This capability is particularly valuable in cancer management, where accurate imaging is essential for guiding treatment decisions and monitoring therapeutic outcomes.

Biocompatibility and Biodegradability

Toxicity and Clearance: Biocompatibility studies indicated that sugar-based biopolymers exhibited minimal cytotoxicity and were well-tolerated in animal models. The biodegradable nature of these polymers facilitated their clearance from the body, reducing the risk of long-term toxicity [9]. Histological analysis showed no significant damage to major organs, indicating the safety of repeated administrations of these Nano carriers. The high biocompatibility and biodegradability of sugar-based biopolymers are critical advantages, making them suitable for repeated use in clinical settings [10]. Their safe degradation and elimination from the body minimize potential side effects, making them preferable over non-biodegradable materials.

Conclusion

Sugar-based biopolymers have demonstrated immense potential in revolutionizing cancer imaging and therapy within the realm of nanomedicine. Their unique properties, including biocompatibility, biodegradability, and specificity for cancer cell receptors, make them ideal candidates for the development of targeted Nano carriers. The advancements in their synthesis, functionalization, and application have led to significant improvements in drug delivery efficiency, imaging contrast, and therapeutic outcomes. As research progresses, the integration of sugar-based biopolymers into clinical practice holds promise for more effective and personalized cancer treatments. Future work should focus on refining the design of these Nano carriers to further enhance their targeting capabilities and exploring their use in combination with other therapeutic modalities, such as immunotherapy and gene therapy. Ultimately, sugar-based biopolymers represent a new frontier in the fight against cancer, offering hope for more effective and less invasive treatment options.

Acknowledgement

None

Conflict of Interest

None

References

1. Chopra H, Kumar S, Singh I (2021)Biopolymer-based Scaffolds for Tissue Engineering Applications. Curr Drug Targets 22: 282-295.

Indexed at, Google Scholar, Crossref

2. Jo YK, Lee D (2020)Biopolymer Microparticles Prepared by Microfluidics for Biomedical Applications. Small 16: e1903736-e1903739.

Indexed at, Google Scholar, Crossref

3. Jiménez-Gómez CP, Cecilia JA (2020)Chitosan: A Natural Biopolymer with a Wide and Varied Range of Applications. Mol 25: 3981-3985.

Indexed at, Google Scholar, Crossref

4. Negm NA, Hefni HHH, Abd-Elaal AAA, Badr EA, Abou-Kana MTH, et al. (2020)Advancement on modification of chitosan biopolymer and its potential applications. Int J Biol Macromol 152: 681-702.

Indexed at, Google Scholar, Crossref

5. Negm NA, Kana MTHA, Abubshait SA, Betiha MA (2020)Effectuality of chitosan biopolymer and its derivatives during antioxidant applications. Int J Biol Macromol 164: 1342-1369.

Indexed at, Google Scholar, Crossref

6. Díez-Pascual AM (2019)Synthesis and Applications of Biopolymer Composites. Int J Mol Sci 20: 2321-2324.

Indexed at, Google Scholar, Crossref

7. Zhao S, Malfait WJ, Guerrero-Alburquerque N, Koebel MM, Nyström G, et al. (2018)Biopolymer Aerogels and Foams: Chemistry, Properties, and Applications. Angew Chem Int Ed Engl 57: 7580-7608.

Indexed at, Google Scholar, Crossref

8. Nascimento TRL, Campos Velo MMA, Costa Cruz SBS, Gondim BLC, Mondelli RFL, et al.( 2019)Current Applications of Biopolymer-based Scaffolds and Nanofibers as Drug Delivery Systems. Curr Pharm Des 25: 3997-4012

Indexed at, Google Scholar, Crossref

9. Arif U, Haider S, Haider A, Khan N, Alghyamah AA, et al. (2019)Biocompatible Polymers and their Potential Biomedical Applications: A Review. Curr Pharm Des 25: 3608-3619.

Indexed at, Google Scholar, Crossref

10. Costa R, Costa L, Rodrigues I, Meireles C, Soares R, et al. (2021)Biocompatibility of the Biopolymer Cyanoflan for Applications in Skin Wound Healing. Mar Drugs 19: 147-149.

Indexed at, Google Scholar, Crossref